Loomis Sayles & CO L P Novavax Inc Transaction History

Loomis Sayles & CO L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$6.81 - $9.74 $8,056 - $11,522	1,183 New	1,183 $9,000
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $3,674 - $7,962	638 Added 510.4%	763 $5,000
Q4 2022 Feb 10, 2023	BUY	$8.86 - $25.04 $868 - $2,453	98 Added 362.96%	125 $1,000
Q2 2022 Aug 05, 2022	BUY	$36.28 - $75.29 $979 - $2,032	27 New	27 $1,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.